Odonate Therapeutics Statistics
Total Valuation
ODTC has a market cap or net worth of $65.82 million. The enterprise value is $11.10 million.
| Market Cap | 65.82M |
| Enterprise Value | 11.10M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ODTC has 3,849 shares outstanding.
| Shares Outstanding | 3,849 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 6,705.88.
| PE Ratio | 6,705.88 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.61 |
| P/FCF Ratio | 7.53 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 1.52 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 1.27 |
Financial Position
The company has a current ratio of 111.72, with a Debt / Equity ratio of 0.02.
| Current Ratio | 111.72 |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.26 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.77% and return on invested capital (ROIC) is -0.57%.
| Return on Equity (ROE) | 6.77% |
| Return on Assets (ROA) | 6.63% |
| Return on Capital (ROIC) | -0.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $53,467 |
| Employee Count | 137 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ODTC has paid $2.12 million in taxes.
| Income Tax | 2.12M |
| Effective Tax Rate | 22.44% |
Stock Price Statistics
The stock price has increased by +3.64% in the last 52 weeks. The beta is -0.33, so ODTC's price volatility has been lower than the market average.
| Beta (5Y) | -0.33 |
| 52-Week Price Change | +3.64% |
| 50-Day Moving Average | 16,291.35 |
| 200-Day Moving Average | 17,180.59 |
| Relative Strength Index (RSI) | 52.04 |
| Average Volume (20 Days) | 4 |
Short Selling Information
The latest short interest is 37, so 0.96% of the outstanding shares have been sold short.
| Short Interest | 37 |
| Short Previous Month | 51 |
| Short % of Shares Out | 0.96% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | -21,000 |
| Operating Income | -817,000 |
| Pretax Income | 9.44M |
| Net Income | 7.33M |
| EBITDA | -796,000 |
| EBIT | -817,000 |
| Earnings Per Share (EPS) | $2.55 |
Balance Sheet
The company has $57.02 million in cash and $2.30 million in debt, giving a net cash position of $54.72 million or $14,216.68 per share.
| Cash & Cash Equivalents | 57.02M |
| Total Debt | 2.30M |
| Net Cash | 54.72M |
| Net Cash Per Share | $14,216.68 |
| Equity (Book Value) | 108.12M |
| Book Value Per Share | 28,090.67 |
| Working Capital | 56.58M |
Cash Flow
| Operating Cash Flow | 8.74M |
| Capital Expenditures | n/a |
| Free Cash Flow | 8.74M |
| FCF Per Share | $3.05 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ODTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -98,440.07% |
| Shareholder Yield | -98,440.07% |
| Earnings Yield | 11.13% |
| FCF Yield | 13.28% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 9, 2024. It was a reverse split with a ratio of 1:5.
| Last Split Date | Apr 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |